| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.786 | 0.013 | 0.787 | Caspase 9 stimulant | 0.787 0.013 CID_154699648 | CID_154699648 | |
| 0.718 | 0.028 | 0.854 | Antiinflammatory | 0.854 0.009 CID_154699648 | CID_154699648 | |
| 0.716 | 0.028 | 0.758 | Apoptosis agonist | 0.758 0.022 CID_154699648 | CID_154699648 | |
| 0.662 | 0.004 | 0.662 | GABA C receptor rho-3 antagonist | |||
| 0.631 | 0.009 | 0.631 | Caspase 3 stimulant | 0.516 0.018 CID_154699648 | ||
| 0.594 | 0.014 | 0.594 | 12-Lipoxygenase inhibitor | |||
| 0.583 | 0.013 | 0.755 | Antioxidant | 0.755 0.005 CID_154699648 | CID_154699648 | |
| 0.592 | 0.032 | 0.865 | Transcription factor NF kappa B inhibitor | 0.865 0.009 CID_154699648 | CID_154699648 | |
| 0.557 | 0.013 | 0.557 | Lipoxygenase inhibitor | |||
| 0.567 | 0.029 | 0.567 | 15-Lipoxygenase inhibitor | |||
| 0.539 | 0.013 | 0.692 | Free radical scavenger | 0.692 0.005 CID_154699648 | CID_154699648 | |
| 0.519 | 0.024 | 0.519 | 5 Hydroxytryptamine release stimulant | 0.338 0.059 CID_154699648 | ||
| 0.518 | 0.028 | 0.579 | Immunosuppressant | 0.579 0.016 CID_154699648 | CID_154699648 | |
| 0.494 | 0.008 | 0.494 | Anesthetic general | 0.459 0.011 CID_154699648 | ||
| 0.489 | 0.007 | 0.749 | Melanin inhibitor | 0.749 0.003 CID_154699648 | CID_154699648 | |
| 0.475 | 0.005 | 0.514 | NOS3 expression enhancer | 0.514 0.005 CID_154699648 | CID_154699648 | |
| 0.486 | 0.034 | 0.611 | Histamine release inhibitor | 0.611 0.009 CID_154699648 | CID_154699648 | |
| 0.453 | 0.007 | 0.453 | 5 Hydroxytryptamine uptake stimulant | 0.192 0.169 CID_154699648 | ||
| 0.479 | 0.036 | 0.479 | Aldehyde oxidase inhibitor | |||
| 0.459 | 0.026 | 0.459 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.454 | 0.04 | 0.665 | Cholesterol antagonist | 0.665 0.011 CID_154699648 | CID_154699648 | |
| 0.425 | 0.023 | 0.576 | Nitric oxide antagonist | 0.576 0.011 CID_154699648 | CID_154699648 | |
| 0.423 | 0.023 | 0.423 | Superoxide dismutase inhibitor | |||
| 0.393 | 0.009 | 0.393 | Protein-tyrosine phosphatase inhibitor | 0.286 0.022 CID_154699648 | ||
| 0.441 | 0.06 | 0.705 | Antibacterial | 0.705 0.008 CID_154699648 | CID_154699648 | |
| 0.385 | 0.005 | 0.385 | 5-Lipoxygenase inhibitor | |||
| 0.382 | 0.012 | 0.714 | Monophenol monooxygenase inhibitor | 0.714 0.004 CID_154699648 | CID_154699648 | |
| 0.374 | 0.011 | 0.374 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.351 | 0.008 | 0.351 | Protein-tyrosine phosphatase 1B inhibitor | 0.264 0.014 CID_154699648 | ||
| 0.393 | 0.051 | 0.779 | Antithrombotic | 0.779 0.005 CID_154699648 | CID_154699648 | |
| 0.369 | 0.034 | 0.708 | Hypoglycemic | 0.708 0.005 CID_154699648 | CID_154699648 | |
| 0.362 | 0.03 | 0.362 | Pyruvate kinase inhibitor | |||
| 0.337 | 0.011 | 0.346 | Neurotrophic factor enhancer | 0.346 0.009 CID_154699648 | CID_154699648 | |
| 0.352 | 0.028 | 0.352 | Peroxidase inhibitor | |||
| 0.353 | 0.044 | 0.38 | Hypoxia-inducible factor 1 alpha inhibitor | 0.38 0.036 CID_154699648 | CID_154699648 | |
| 0.359 | 0.05 | 0.517 | Spasmolytic | 0.517 0.021 CID_154699648 | CID_154699648 | |
| 0.31 | 0.004 | 0.31 | TRPA1 agonist | 0.224 0.007 CID_154699648 | ||
| 0.309 | 0.005 | 0.309 | GABA C receptor rho-2 antagonist | |||
| 0.319 | 0.019 | 0.319 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.337 | 0.039 | 0.337 | Transcription factor STAT inhibitor | |||
| 0.332 | 0.039 | 0.332 | Transcription factor STAT3 inhibitor | |||
| 0.303 | 0.015 | 0.303 | MAO A inhibitor | |||
| 0.296 | 0.01 | 0.296 | Cystathionine beta-synthase inhibitor | 0.264 0.013 CID_154699648 | ||
| 0.285 | 0.005 | 0.285 | GABA C receptor antagonist | |||
| 0.287 | 0.022 | 0.45 | Interferon gamma antagonist | 0.45 0.008 CID_154699648 | CID_154699648 | |
| 0.331 | 0.066 | 0.536 | Apoptosis antagonist | 0.536 0.016 CID_154699648 | CID_154699648 | |
| 0.313 | 0.051 | 0.313 | Insulysin inhibitor | |||
| 0.305 | 0.047 | 0.374 | Hypolipemic | 0.374 0.03 CID_154699648 | CID_154699648 | |
| 0.272 | 0.016 | 0.272 | Succinate dehydrogenase inhibitor | |||
| 0.277 | 0.022 | 0.378 | Lipid peroxidase inhibitor | 0.378 0.011 CID_154699648 | CID_154699648 | |
| 0.263 | 0.01 | 0.263 | Neurotrophic factor | 0.189 0.033 CID_154699648 | ||
| 0.259 | 0.011 | 0.439 | Xanthine oxidase inhibitor | 0.439 0.004 CID_154699648 | CID_154699648 | |
| 0.271 | 0.024 | 0.271 | Insulin sensitizer | 0.243 0.038 CID_154699648 | ||
| 0.253 | 0.008 | 0.253 | Estrogen antagonist | 0.123 0.049 CID_154699648 | ||
| 0.25 | 0.007 | 0.25 | Estrogen receptor beta antagonist | |||
| 0.276 | 0.034 | 0.555 | Non-steroidal antiinflammatory agent | 0.555 0.005 CID_154699648 | CID_154699648 | |
| 0.247 | 0.005 | 0.255 | Vanilloid 1 agonist | 0.255 0.005 CID_154699648 | CID_154699648 | |
| 0.25 | 0.009 | 0.614 | Cyclooxygenase 3 inhibitor | 0.614 0.002 CID_154699648 | CID_154699648 | |
| 0.243 | 0.005 | 0.243 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.349 | 0.116 | 0.428 | 5 Hydroxytryptamine release inhibitor | 0.428 0.062 CID_154699648 | CID_154699648 | |
| 0.247 | 0.014 | 0.247 | GABA C receptor agonist | |||
| 0.252 | 0.021 | 0.252 | Cyclooxygenase 1 inhibitor | 0.154 0.055 CID_154699648 | ||
| 0.323 | 0.092 | 0.323 | Prostaglandin dehydrogenase inhibitor | |||
| 0.237 | 0.006 | 0.237 | Estrogen receptor alpha antagonist | |||
| 0.279 | 0.049 | 0.279 | Psychostimulant | 0.276 0.05 CID_154699648 | ||
| 0.36 | 0.131 | 0.631 | Alpha-glucosidase inhibitor | 0.631 0.047 CID_154699648 | CID_154699648 | |
| 0.255 | 0.027 | 0.255 | MAO inhibitor | |||
| 0.232 | 0.005 | 0.232 | GABA C receptor rho-1 antagonist | |||
| 0.233 | 0.006 | 0.233 | Papain-like protease (SARS coronavirus) inhibitor | 0.129 0.061 CID_154699648 | ||
| 0.249 | 0.025 | 0.249 | Phospholipase C inhibitor | 0.189 0.052 CID_154699648 | ||
| 0.251 | 0.028 | 0.545 | Amylase inhibitor | 0.545 0.005 CID_154699648 | CID_154699648 | |
| 0.271 | 0.051 | 0.271 | Amyloid beta aggregation inhibitor | 0.2 0.078 CID_154699648 | ||
| 0.242 | 0.023 | 0.242 | Heat shock protein 90 antagonist | |||
| 0.223 | 0.006 | 0.223 | Adenylate cyclase stimulant | 0.166 0.04 CID_154699648 | ||
| 0.224 | 0.012 | 0.224 | CF transmembrane conductance regulator agonist | 0.159 0.061 CID_154699648 | ||
| 0.232 | 0.021 | 0.232 | Aldehyde dehydrogenase inhibitor | 0.224 0.023 CID_154699648 | ||
| 0.24 | 0.03 | 0.24 | Heat shock protein 90 alpha antagonist | |||
| 0.276 | 0.067 | 0.301 | DNA damaging | 0.301 0.057 CID_154699648 | CID_154699648 | |
| 0.223 | 0.015 | 0.223 | Arachidonic acid antagonist | 0.16 0.076 CID_154699648 | ||
| 0.255 | 0.047 | 0.255 | RNA-directed DNA polymerase inhibitor | 0.219 0.075 CID_154699648 | ||
| 0.212 | 0.004 | 0.212 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.267 | 0.061 | 0.397 | Vasodilator | 0.397 0.024 CID_154699648 | CID_154699648 | |
| 0.206 | 0.006 | 0.206 | DOPA decarboxylase inhibitor | |||
| 0.204 | 0.004 | 0.204 | GABA aminotransferase inhibitor | 0.167 0.005 CID_154699648 | ||
| 0.209 | 0.009 | 0.209 | Creatine kinase inhibitor | |||
| 0.221 | 0.022 | 0.221 | Cholesterol synthesis inhibitor | 0.151 0.044 CID_154699648 | ||
| 0.293 | 0.096 | 0.42 | Angiogenesis inhibitor | 0.42 0.048 CID_154699648 | CID_154699648 | |
| 0.215 | 0.018 | 0.215 | Toll-Like receptor 2 antagonist | 0.103 0.1 CID_154699648 | ||
| 0.244 | 0.049 | 0.367 | DNA methyltransferase I inhibitor | 0.367 0.012 CID_154699648 | CID_154699648 | |
| 0.241 | 0.046 | 0.524 | Hepatoprotectant | 0.524 0.006 CID_154699648 | CID_154699648 | |
| 0.263 | 0.069 | 0.474 | Tumour necrosis factor alpha release inhibitor | 0.474 0.016 CID_154699648 | CID_154699648 | |
| 0.218 | 0.025 | 0.376 | ATPase inhibitor | 0.376 0.004 CID_154699648 | CID_154699648 | |
| 0.244 | 0.051 | 0.39 | DNA methylase inhibitor | 0.39 0.012 CID_154699648 | CID_154699648 | |
| 0.204 | 0.012 | 0.204 | Porphobilinogen synthase inhibitor | |||
| 0.216 | 0.028 | 0.216 | Anesthetic local | |||
| 0.237 | 0.051 | 0.237 | Sigma receptor agonist | |||
| 0.192 | 0.007 | 0.192 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.24 | 0.058 | 0.413 | Peptidyltransferase inhibitor | 0.413 0.006 CID_154699648 | CID_154699648 | |
| 0.211 | 0.03 | 0.211 | Neurotensin receptor agonist | |||
| 0.21 | 0.031 | 0.3 | Alpha-N-acetylglucosaminidase inhibitor | 0.3 0.016 CID_154699648 | CID_154699648 | |
| 0.186 | 0.007 | 0.186 | Prostaglandin EP2 antagonist | 0.13 0.013 CID_154699648 | ||
| 0.282 | 0.103 | 0.452 | Vasodilator, coronary | 0.452 0.023 CID_154699648 | CID_154699648 | |
| 0.214 | 0.036 | 0.214 | Phospholipase A2 inhibitor | 0.191 0.048 CID_154699648 | ||
| 0.285 | 0.107 | 0.285 | Calcium channel activator | |||
| 0.246 | 0.069 | 0.418 | DNA synthesis inhibitor | 0.418 0.019 CID_154699648 | CID_154699648 | |
| 0.278 | 0.1 | 0.278 | Sodium/bile acid cotransporter inhibitor | |||
| 0.188 | 0.011 | 0.188 | Prolactin inhibitor | |||
| 0.23 | 0.057 | 0.461 | Platelet adhesion inhibitor | 0.461 0.007 CID_154699648 | CID_154699648 | |
| 0.226 | 0.053 | 0.234 | Nitric-oxide synthase stimulant | 0.234 0.045 CID_154699648 | CID_154699648 | |
| 0.188 | 0.017 | 0.271 | Topoisomerase II alpha inhibitor | 0.271 0.009 CID_154699648 | CID_154699648 | |
| 0.179 | 0.009 | 0.179 | Glutamate decarboxylase inhibitor | |||
| 0.177 | 0.008 | 0.177 | Vanilloid agonist | 0.102 0.031 CID_154699648 | ||
| 0.26 | 0.092 | 0.541 | Immunostimulant | 0.541 0.024 CID_154699648 | CID_154699648 | |
| 0.185 | 0.017 | 0.197 | Mucolytic | 0.197 0.014 CID_154699648 | CID_154699648 | |
| 0.19 | 0.025 | 0.19 | Ferrochelatase inhibitor | |||
| 0.222 | 0.057 | 0.222 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.261 | 0.096 | 0.261 | Streptokinase A inhibitor | |||
| 0.168 | 0.004 | 0.26 | Leukotriene B4 antagonist | 0.26 0.003 CID_154699648 | CID_154699648 | |
| 0.189 | 0.026 | 0.189 | Interleukin 4 antagonist | 0.176 0.031 CID_154699648 | ||
| 0.175 | 0.014 | 0.184 | Heat shock protein 70 antagonist | 0.184 0.01 CID_154699648 | CID_154699648 | |
| 0.172 | 0.012 | 0.172 | CYP2A6 inhibitor | |||
| 0.168 | 0.013 | 0.218 | Transcription factor NF kappa B stimulant | 0.218 0.008 CID_154699648 | CID_154699648 | |
| 0.214 | 0.059 | 0.214 | I kappa B kinase epsilon inhibitor | |||
| 0.168 | 0.015 | 0.168 | Ca2+-transporting ATPase inhibitor | 0.159 0.025 CID_154699648 | ||
| 0.164 | 0.012 | 0.164 | Anabolic | 0.107 0.053 CID_154699648 | ||
| 0.238 | 0.088 | 0.341 | Interleukin agonist | 0.341 0.031 CID_154699648 | CID_154699648 | |
| 0.187 | 0.038 | 0.479 | Hemostatic | 0.479 0.005 CID_154699648 | CID_154699648 | |
| 0.16 | 0.012 | 0.16 | Aromatase inhibitor | |||
| 0.228 | 0.08 | 0.75 | Angiogenesis stimulant | 0.75 0.004 CID_154699648 | CID_154699648 | |
| 0.154 | 0.01 | 0.154 | Leukotriene antagonist | 0.133 0.013 CID_154699648 | ||
| 0.188 | 0.046 | 0.328 | Protein kinase stimulant | 0.328 0.014 CID_154699648 | CID_154699648 | |
| 0.17 | 0.028 | 0.491 | Expectorant | 0.491 0.004 CID_154699648 | CID_154699648 | |
| 0.17 | 0.03 | 0.17 | Chelator | |||
| 0.259 | 0.121 | 0.259 | Vasodilator, peripheral | 0.225 0.149 CID_154699648 | ||
| 0.143 | 0.005 | 0.143 | Fatty acid synthase inhibitor | 0.083 0.017 CID_154699648 | ||
| 0.167 | 0.03 | 0.201 | Microtubule formation inhibitor | 0.201 0.02 CID_154699648 | CID_154699648 | |
| 0.15 | 0.013 | 0.15 | CDC25A inhibitor | 0.07 0.057 CID_154699648 | ||
| 0.18 | 0.042 | 0.192 | Alkaline phosphatase inhibitor | 0.192 0.036 CID_154699648 | CID_154699648 | |
| 0.154 | 0.017 | 0.252 | Phosphofructokinase-1 inhibitor | 0.252 0.007 CID_154699648 | CID_154699648 | |
| 0.148 | 0.012 | 0.148 | Ornithine decarboxylase inhibitor | 0.123 0.024 CID_154699648 | ||
| 0.143 | 0.008 | 0.143 | Estrogen receptor beta agonist | 0.074 0.015 CID_154699648 | ||
| 0.16 | 0.025 | 0.219 | Photosensitizer | 0.219 0.009 CID_154699648 | CID_154699648 | |
| 0.167 | 0.032 | 0.167 | Alpha 2b adrenoreceptor antagonist | |||
| 0.183 | 0.048 | 0.183 | Catenin beta inhibitor | 0.139 0.135 CID_154699648 | ||
| 0.192 | 0.058 | 0.192 | Tumour necrosis factor antagonist | |||
| 0.168 | 0.035 | 0.168 | Adenylate cyclase inhibitor | 0.11 0.075 CID_154699648 | ||
| 0.137 | 0.003 | 0.137 | Retinoid X alpha receptor agonist | |||
| 0.152 | 0.019 | 0.255 | Triose-phosphate isomerase inhibitor | 0.255 0.007 CID_154699648 | CID_154699648 | |
| 0.192 | 0.06 | 0.192 | Mcl-1 antagonist | |||
| 0.141 | 0.011 | 0.141 | Leukotriene synthesis inhibitor | |||
| 0.176 | 0.046 | 0.176 | Tubulin antagonist | |||
| 0.154 | 0.025 | 0.178 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.178 0.02 CID_154699648 | CID_154699648 | |
| 0.191 | 0.062 | 0.191 | Growth hormone agonist | |||
| 0.178 | 0.049 | 0.324 | Insulin secretagoues | 0.324 0.01 CID_154699648 | CID_154699648 | |
| 0.162 | 0.034 | 0.162 | MAO B inhibitor | |||
| 0.134 | 0.009 | 0.134 | CDC25B inhibitor | |||
| 0.129 | 0.003 | 0.129 | Retinoid X receptor agonist | |||
| 0.177 | 0.051 | 0.319 | Hexokinase inhibitor | 0.319 0.009 CID_154699648 | CID_154699648 | |
| 0.177 | 0.052 | 0.177 | Cyclooxygenase inhibitor | 0.122 0.097 CID_154699648 | ||
| 0.137 | 0.012 | 0.137 | Estrogen agonist | 0.098 0.018 CID_154699648 | ||
| 0.137 | 0.014 | 0.137 | Beta tubulin antagonist | |||
| 0.13 | 0.008 | 0.13 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.15 | 0.029 | 0.388 | Mediator release inhibitor | 0.388 0.005 CID_154699648 | CID_154699648 | |
| 0.135 | 0.016 | 0.135 | Glutathione S-transferase inhibitor | 0.076 0.069 CID_154699648 | ||
| 0.183 | 0.065 | 0.183 | Dual specificity phosphatase inhibitor | |||
| 0.122 | 0.004 | 0.122 | MAP kinase kinase 7 inhibitor | |||
| 0.146 | 0.028 | 0.146 | Adenylate kinase inhibitor | 0.1 0.067 CID_154699648 | ||
| 0.135 | 0.017 | 0.135 | Keratolytic | |||
| 0.141 | 0.025 | 0.141 | Androgen antagonist | |||
| 0.146 | 0.03 | 0.146 | Carbonic anhydrase III inhibitor | 0.094 0.07 CID_154699648 | ||
| 0.128 | 0.014 | 0.157 | Glycine receptor antagonist | 0.157 0.006 CID_154699648 | CID_154699648 | |
| 0.225 | 0.111 | 0.225 | Gastrin inhibitor | |||
| 0.132 | 0.019 | 0.132 | Glutamate dehydrogenase inhibitor | 0.081 0.044 CID_154699648 | ||
| 0.284 | 0.171 | 0.284 | Calcium channel L-type activator | |||
| 0.157 | 0.046 | 0.311 | Topoisomerase II inhibitor | 0.311 0.017 CID_154699648 | CID_154699648 | |
| 0.167 | 0.056 | 0.167 | Thiol protease inhibitor | |||
| 0.139 | 0.028 | 0.139 | Electron transport complex I inhibitor | |||
| 0.115 | 0.005 | 0.115 | Exportin-1 inhibitor | |||
| 0.123 | 0.013 | 0.123 | TRPA1 antagonist | |||
| 0.121 | 0.012 | 0.143 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.143 0.008 CID_154699648 | CID_154699648 | |
| 0.141 | 0.031 | 0.141 | Transcription factor STAT6 inhibitor | |||
| 0.138 | 0.03 | 0.138 | Urease inhibitor | |||
| 0.13 | 0.023 | 0.13 | Histidine decarboxylase inhibitor | |||
| 0.14 | 0.033 | 0.297 | UDP-glucose 4-epimerase inhibitor | 0.297 0.01 CID_154699648 | CID_154699648 | |
| 0.204 | 0.097 | 0.304 | Antiamyloidogenic | 0.304 0.05 CID_154699648 | CID_154699648 | |
| 0.131 | 0.026 | 0.171 | Carbonic anhydrase XIII inhibitor | 0.171 0.018 CID_154699648 | CID_154699648 | |
| 0.141 | 0.036 | 0.141 | Alpha 2c adrenoreceptor antagonist | |||
| 0.117 | 0.013 | 0.117 | Alpha tubulin antagonist | |||
| 0.139 | 0.035 | 0.139 | Carbonic anhydrase XV inhibitor | |||
| 0.126 | 0.022 | 0.126 | Inducible nitric-oxide synthase inhibitor | |||
| 0.129 | 0.026 | 0.129 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.107 | 0.004 | 0.107 | Dihydroorotate oxidase inhibitor | |||
| 0.121 | 0.019 | 0.121 | Bile acid receptor antagonist | |||
| 0.135 | 0.033 | 0.376 | Beta glucuronidase inhibitor | 0.376 0.004 CID_154699648 | CID_154699648 | |
| 0.127 | 0.025 | 0.127 | Phosphodiesterase 4D inhibitor | |||
| 0.114 | 0.012 | 0.114 | Xanthine dehydrogenase inhibitor | 0.07 0.031 CID_154699648 | ||
| 0.112 | 0.012 | 0.112 | Beta 3 adrenoreceptor antagonist | |||
| 0.188 | 0.088 | 0.188 | Histone acetyltransferase inhibitor | |||
| 0.105 | 0.006 | 0.105 | Sphingosine kinase 2 inhibitor | |||
| 0.103 | 0.006 | 0.103 | Squalene synthetase inhibitor | 0.088 0.007 CID_154699648 | ||
| 0.146 | 0.049 | 0.146 | Proteasome inhibitor | |||
| 0.131 | 0.034 | 0.183 | Toll-Like receptor 4 antagonist | 0.183 0.009 CID_154699648 | CID_154699648 | |
| 0.153 | 0.056 | 0.153 | Bone formation stimulant | 0.123 0.083 CID_154699648 | ||
| 0.111 | 0.015 | 0.111 | Estrogen-related receptor beta agonist | |||
| 0.1 | 0.004 | 0.1 | Melatonin 2 agonist | 0.052 0.01 CID_154699648 | ||
| 0.112 | 0.017 | 0.116 | T cell inhibitor | 0.116 0.015 CID_154699648 | CID_154699648 | |
| 0.119 | 0.024 | 0.119 | Alpha 2d adrenoreceptor antagonist | |||
| 0.154 | 0.062 | 0.326 | Cell wall synthesis inhibitor | 0.326 0.009 CID_154699648 | CID_154699648 | |
| 0.301 | 0.211 | 0.301 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.098 | 0.009 | 0.098 | Estrogen receptor alpha agonist | |||
| 0.142 | 0.054 | 0.142 | Antibacterial (Helicobacter pylori) | |||
| 0.096 | 0.009 | 0.096 | Sphingosine kinase inhibitor | |||
| 0.124 | 0.037 | 0.124 | Breast cancer-resistant protein inhibitor | |||
| 0.102 | 0.015 | 0.102 | Beta adrenoreceptor antagonist | |||
| 0.11 | 0.023 | 0.11 | Lipase inhibitor | 0.07 0.055 CID_154699648 | ||
| 0.189 | 0.102 | 0.333 | Cyclic AMP phosphodiesterase inhibitor | 0.333 0.03 CID_154699648 | CID_154699648 | |
| 0.101 | 0.014 | 0.101 | Alpha 2 adrenoreceptor agonist | |||
| 0.091 | 0.005 | 0.091 | Adenylate cyclase 1 inhibitor | |||
| 0.121 | 0.035 | 0.121 | Electrolyte absorption antagonist | |||
| 0.095 | 0.009 | 0.095 | Potassium channel Kv1.3 blocker | |||
| 0.104 | 0.019 | 0.104 | Ca(v)3.1 blocker | |||
| 0.112 | 0.03 | 0.112 | Adrenaline agonist | |||
| 0.142 | 0.06 | 0.142 | NADPH oxidase inhibitor | 0.125 0.076 CID_154699648 | ||
| 0.129 | 0.048 | 0.129 | Caspase 3 inhibitor | |||
| 0.129 | 0.05 | 0.278 | Topoisomerase I inhibitor | 0.278 0.013 CID_154699648 | CID_154699648 | |
| 0.124 | 0.045 | 0.329 | AMP-activated protein kinase stimulant | 0.329 0.005 CID_154699648 | CID_154699648 | |
| 0.097 | 0.019 | 0.097 | Biliverdin reductase inhibitor | |||
| 0.093 | 0.018 | 0.129 | Neuraminidase inhibitor | 0.129 0.008 CID_154699648 | CID_154699648 | |
| 0.115 | 0.04 | 0.278 | Antineoplastic antibiotic | 0.278 0.011 CID_154699648 | CID_154699648 | |
| 0.079 | 0.004 | 0.079 | Leukotriene B4 receptor 1 antagonist | 0.05 0.007 CID_154699648 | ||
| 0.083 | 0.008 | 0.083 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.115 | 0.041 | 0.115 | Nitric-oxide synthase inhibitor | |||
| 0.1 | 0.026 | 0.1 | HIV-1 integrase (3'-Processing) inhibitor | 0.069 0.039 CID_154699648 | ||
| 0.097 | 0.024 | 0.097 | HIV-1 integrase (Strand Transfer) inhibitor | 0.069 0.036 CID_154699648 | ||
| 0.098 | 0.025 | 0.098 | Dopamine D1 antagonist | |||
| 0.079 | 0.006 | 0.079 | Dopamine D5 agonist | |||
| 0.255 | 0.183 | 0.255 | Transcription factor inhibitor | |||
| 0.102 | 0.03 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.123 0.015 CID_154699648 | CID_154699648 | |
| 0.179 | 0.108 | 0.179 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.136 | 0.065 | 0.136 | Cyclooxygenase 2 inhibitor | |||
| 0.148 | 0.079 | 0.271 | Diuretic | 0.271 0.027 CID_154699648 | CID_154699648 | |
| 0.074 | 0.005 | 0.074 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.078 | 0.009 | 0.078 | TRPM8 blocker | |||
| 0.075 | 0.006 | 0.075 | Dopamine beta hydroxylase inhibitor | |||
| 0.089 | 0.02 | 0.089 | Androgen agonist | |||
| 0.11 | 0.043 | 0.11 | Alcohol dehydrogenase inhibitor | 0.098 0.054 CID_154699648 | ||
| 0.095 | 0.028 | 0.095 | CC chemokine 5 receptor agonist | |||
| 0.107 | 0.041 | 0.138 | Thioredoxin inhibitor | 0.138 0.021 CID_154699648 | CID_154699648 | |
| 0.078 | 0.013 | 0.078 | Beta 2 adrenoreceptor antagonist | |||
| 0.103 | 0.038 | 0.103 | Carbonic anhydrase VI inhibitor | |||
| 0.112 | 0.047 | 0.112 | Sphingomyelinase inhibitor | |||
| 0.081 | 0.016 | 0.081 | Transcription factor RelA inhibitor | |||
| 0.104 | 0.04 | 0.165 | NADH dehydrogenase inhibitor | 0.165 0.014 CID_154699648 | CID_154699648 | |
| 0.074 | 0.01 | 0.074 | Pregnane X receptor antagonist | |||
| 0.126 | 0.062 | 0.126 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.179 | 0.117 | 0.179 | ErbB-1 antagonist | |||
| 0.072 | 0.01 | 0.074 | Factor III inhibitor | 0.074 0.009 CID_154699648 | CID_154699648 | |
| 0.096 | 0.034 | 0.096 | D-Ala-D-Ala ligase inhibitor | |||
| 0.084 | 0.023 | 0.084 | Purinergic P2X1 antagonist | |||
| 0.066 | 0.005 | 0.066 | Kainate receptor agonist | |||
| 0.097 | 0.036 | 0.097 | Macrophage migration inhibitory factor inhibitor | |||
| 0.105 | 0.044 | 0.139 | Phosphodiesterase 6D inhibitor | 0.139 0.013 CID_154699648 | CID_154699648 | |
| 0.089 | 0.029 | 0.089 | Glycine receptor agonist | 0.075 0.045 CID_154699648 | ||
| 0.064 | 0.005 | 0.064 | ATP citrate lysase inhibitor | |||
| 0.124 | 0.066 | 0.168 | DNA polymerase I inhibitor | 0.168 0.04 CID_154699648 | CID_154699648 | |
| 0.067 | 0.009 | 0.067 | Nicotinic acid receptor agonist | |||
| 0.097 | 0.04 | 0.097 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.077 | 0.02 | 0.077 | Beta 1 adrenoreceptor antagonist | |||
| 0.061 | 0.005 | 0.061 | Retinoid X receptor antagonist | |||
| 0.087 | 0.033 | 0.087 | HIV-1 integrase inhibitor | |||
| 0.258 | 0.204 | 0.77 | Cyclophilin D inhibitor | 0.77 0.008 CID_154699648 | CID_154699648 | |
| 0.079 | 0.026 | 0.14 | Neuraminidase (influenza) inhibitor | 0.14 0.008 CID_154699648 | CID_154699648 | |
| 0.091 | 0.039 | 0.091 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.077 | 0.025 | 0.077 | Alcohol oxidase inhibitor | |||
| 0.067 | 0.017 | 0.067 | Leukotriene C antagonist | |||
| 0.075 | 0.025 | 0.075 | Carbonic anhydrase VB inhibitor | |||
| 0.052 | 0.003 | 0.052 | Alpha 2b adrenoreceptor agonist | |||
| 0.057 | 0.009 | 0.057 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.108 | 0.06 | 0.108 | Aminopeptidase B inhibitor | |||
| 0.101 | 0.054 | 0.101 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.101 | 0.055 | 0.101 | Potassium channel (Ca-activated) activator | |||
| 0.072 | 0.026 | 0.072 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.086 | 0.04 | 0.086 | Cathepsin G inhibitor | |||
| 0.052 | 0.006 | 0.138 | Sodium/glucose cotransporter 2 inhibitor | 0.138 0.002 CID_154699648 | CID_154699648 | |
| 0.064 | 0.019 | 0.064 | Vanilloid 2 antagonist | |||
| 0.063 | 0.019 | 0.063 | CD45 antagonist | |||
| 0.075 | 0.031 | 0.075 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.11 | 0.066 | 0.11 | Acetylcholine release stimulant | |||
| 0.065 | 0.022 | 0.065 | Aconitate hydratase inhibitor | |||
| 0.055 | 0.012 | 0.055 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.053 | 0.01 | 0.053 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.154 | 0.111 | 0.169 | P-glycoprotein inhibitor | 0.169 0.091 CID_154699648 | CID_154699648 | |
| 0.08 | 0.037 | 0.08 | Amidase inhibitor | |||
| 0.069 | 0.029 | 0.069 | Heat shock protein 90 beta antagonist | |||
| 0.081 | 0.041 | 0.081 | Aminopeptidase I inhibitor | |||
| 0.05 | 0.009 | 0.05 | Melatonin agonist | |||
| 0.066 | 0.027 | 0.066 | Beta 2 adrenoreceptor agonist | |||
| 0.043 | 0.004 | 0.078 | Vanilloid 2 agonist | 0.078 0.001 CID_154699648 | CID_154699648 | |
| 0.058 | 0.02 | 0.076 | Glucose-6-phosphate isomerase inhibitor | 0.076 0.01 CID_154699648 | CID_154699648 | |
| 0.047 | 0.008 | 0.047 | Retinoid X alpha receptor antagonist | |||
| 0.048 | 0.009 | 0.048 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.078 | 0.04 | 0.078 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.091 | 0.053 | 0.093 | Interleukin 5 antagonist | 0.093 0.051 CID_154699648 | CID_154699648 | |
| 0.091 | 0.054 | 0.131 | ATPase (Vacuolar H+) inhibitor | 0.131 0.013 CID_154699648 | CID_154699648 | |
| 0.054 | 0.017 | 0.054 | Progesterone antagonist | |||
| 0.051 | 0.014 | 0.051 | Retinoic acid alpha receptor agonist | |||
| 0.054 | 0.017 | 0.054 | 5-Alpha-reductase inhibitor | |||
| 0.051 | 0.015 | 0.051 | GABA uptake inhibitor | |||
| 0.041 | 0.005 | 0.041 | Nicotinic acid receptor 2 antagonist | |||
| 0.075 | 0.041 | 0.075 | Carbonic anhydrase VA inhibitor | |||
| 0.073 | 0.039 | 0.073 | Opioid delta receptor antagonist | |||
| 0.068 | 0.033 | 0.068 | Calcium channel P-type blocker | |||
| 0.085 | 0.05 | 0.085 | Thioredoxin reductase inhibitor | |||
| 0.065 | 0.031 | 0.065 | Maillard reaction inhibitor | |||
| 0.049 | 0.015 | 0.049 | Heme oxygenase inhibitor | |||
| 0.037 | 0.003 | 0.037 | Neuraminidase (Influenza B) inhibitor | 0.025 0.008 CID_154699648 | ||
| 0.111 | 0.077 | 0.218 | Alkylator | 0.218 0.022 CID_154699648 | CID_154699648 | |
| 0.038 | 0.005 | 0.038 | Leukotriene B4 receptor 2 antagonist | 0.034 0.007 CID_154699648 | ||
| 0.049 | 0.016 | 0.049 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.061 | 0.029 | 0.061 | NMDA 2A receptor antagonist | |||
| 0.063 | 0.03 | 0.063 | Ryanodine receptor antagonist | |||
| 0.234 | 0.202 | 0.234 | DNA directed DNA polymerase inhibitor | |||
| 0.069 | 0.037 | 0.069 | 5 Hydroxytryptamine 2A agonist | |||
| 0.063 | 0.031 | 0.063 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.059 0.035 CID_154699648 | ||
| 0.078 | 0.046 | 0.078 | GABA B receptor agonist | |||
| 0.095 | 0.064 | 0.095 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.054 | 0.022 | 0.054 | NMDA receptor subunit 3B antagonist | |||
| 0.047 | 0.016 | 0.047 | Diamine oxidase inhibitor | |||
| 0.045 | 0.014 | 0.045 | VCAM-1 antagonist | |||
| 0.122 | 0.092 | 0.122 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.045 | 0.014 | 0.045 | VCAM antagonist | |||
| 0.114 | 0.084 | 0.114 | Acetylcholinesterase inhibitor | |||
| 0.04 | 0.011 | 0.04 | Estrogen-related receptor beta antagonist | |||
| 0.042 | 0.013 | 0.042 | Prostaglandin agonist | |||
| 0.034 | 0.005 | 0.034 | Imidazoline I1 receptor antagonist | |||
| 0.071 | 0.042 | 0.396 | Selectin antagonist | 0.396 0.003 CID_154699648 | CID_154699648 | |
| 0.05 | 0.021 | 0.05 | Kainate receptor antagonist | |||
| 0.075 | 0.047 | 0.075 | MAP3K7 inhibitor | |||
| 0.041 | 0.013 | 0.041 | Catechol O-methyltransferase inhibitor | |||
| 0.036 | 0.008 | 0.141 | Sodium/glucose cotransporter inhibitor | 0.141 0.002 CID_154699648 | CID_154699648 | |
| 0.047 | 0.02 | 0.047 | Sphingosine kinase 1 inhibitor | |||
| 0.052 | 0.025 | 0.052 | Oleamide hydrolase inhibitor | |||
| 0.041 | 0.014 | 0.041 | Melatonin 1 agonist | |||
| 0.034 | 0.007 | 0.034 | Prostaglandin F2 alpha agonist | |||
| 0.147 | 0.12 | 0.147 | Interleukin antagonist | |||
| 0.07 | 0.043 | 0.07 | Carbonic anhydrase V inhibitor | |||
| 0.044 | 0.017 | 0.044 | Leukotriene C4 antagonist | |||
| 0.04 | 0.014 | 0.04 | Prostaglandin EP3 antagonist | |||
| 0.073 | 0.047 | 0.073 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.076 | 0.051 | 0.076 | Alpha 2a adrenoreceptor antagonist | |||
| 0.075 | 0.051 | 0.075 | Vanilloid 4 agonist | |||
| 0.072 | 0.047 | 0.072 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.105 | 0.081 | 0.33 | Cell adhesion inhibitor | 0.33 0.008 CID_154699648 | CID_154699648 | |
| 0.128 | 0.104 | 0.128 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.058 | 0.034 | 0.058 | Thromboxane antagonist | |||
| 0.056 | 0.033 | 0.056 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.043 | 0.02 | 0.043 | Kainate receptor 2 antagonist | |||
| 0.028 | 0.005 | 0.028 | Retinoid X beta receptor antagonist | |||
| 0.048 | 0.025 | 0.048 | Geranyltranstransferase inhibitor | |||
| 0.055 | 0.032 | 0.055 | Thromboxane A2 antagonist | |||
| 0.085 | 0.063 | 0.085 | Opioid antagonist | |||
| 0.067 | 0.047 | 0.067 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.055 | 0.035 | 0.055 | Ornithine carbamoyltransferase inhibitor | |||
| 0.053 | 0.034 | 0.107 | Glucose-6-phosphate translocase inhibitor | 0.107 0.005 CID_154699648 | CID_154699648 | |
| 0.104 | 0.085 | 0.11 | Beta amyloid protein antagonist | 0.11 0.078 CID_154699648 | CID_154699648 | |
| 0.044 | 0.025 | 0.044 | Liver X receptor alpha agonist | |||
| 0.033 | 0.015 | 0.033 | Uridine phosphorylase inhibitor | 0.026 0.022 CID_154699648 | ||
| 0.04 | 0.022 | 0.04 | Glutamate (mGluR8) agonist | |||
| 0.106 | 0.089 | 0.106 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.078 | 0.061 | 0.078 | Opioid kappa receptor antagonist | |||
| 0.05 | 0.033 | 0.05 | Squalene epoxidase inhibitor | |||
| 0.049 | 0.032 | 0.049 | Adenosine deaminase inhibitor | |||
| 0.066 | 0.049 | 0.066 | Potassium channel large-conductance Ca-activated activator | |||
| 0.081 | 0.065 | 0.081 | Alpha 2 adrenoreceptor antagonist | |||
| 0.03 | 0.013 | 0.03 | Thyroid hormone agonist | |||
| 0.024 | 0.007 | 0.024 | Alpha 2c adrenoreceptor agonist | |||
| 0.041 | 0.025 | 0.041 | Dihydropteroate synthase inhibitor | |||
| 0.046 | 0.03 | 0.046 | Beta adrenoreceptor agonist | |||
| 0.038 | 0.022 | 0.038 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.06 | 0.045 | 0.06 | Heme oxygenase stimulant | |||
| 0.054 | 0.039 | 0.054 | Epithelial sodium channel blocker | |||
| 0.029 | 0.014 | 0.029 | Retinoid X gamma receptor antagonist | |||
| 0.036 | 0.022 | 0.036 | Fumarate hydratase inhibitor | |||
| 0.04 | 0.026 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.064 | 0.051 | 0.064 | Alpha adrenoreceptor agonist | |||
| 0.022 | 0.008 | 0.036 | Antibiotic Anthracycline-like | 0.036 0.003 CID_154699648 | CID_154699648 | |
| 0.035 | 0.022 | 0.035 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.058 | 0.045 | 0.058 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.026 | 0.013 | 0.026 | Prostaglandin E2 agonist | |||
| 0.043 | 0.031 | 0.043 | Dihydrofolate reductase inhibitor | |||
| 0.049 | 0.037 | 0.049 | Cannabinoid CB2 receptor antagonist | |||
| 0.185 | 0.174 | 0.185 | Thyroid hormone antagonist | |||
| 0.064 | 0.053 | 0.064 | Glutamate (mGluR6) antagonist | |||
| 0.058 | 0.048 | 0.058 | NMDA 2C receptor antagonist | |||
| 0.12 | 0.11 | 0.329 | Thrombolytic | 0.329 0.019 CID_154699648 | CID_154699648 | |
| 0.033 | 0.024 | 0.033 | Melatonin receptor 1A agonist | |||
| 0.037 | 0.028 | 0.037 | NMDA receptor subunit 3A antagonist | |||
| 0.059 | 0.05 | 0.059 | 5 Hydroxytryptamine 3 agonist | |||
| 0.026 | 0.017 | 0.026 | Complement factor 1s inhibitor | |||
| 0.058 | 0.05 | 0.058 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.027 | 0.019 | 0.027 | Hedgehog signaling activator | |||
| 0.034 | 0.027 | 0.034 | Adenosine uptake inhibitor | |||
| 0.033 | 0.027 | 0.033 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.115 | 0.109 | 0.115 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.05 | 0.044 | 0.147 | Heparanase inhibitor | 0.147 0.003 CID_154699648 | CID_154699648 | |
| 0.069 | 0.063 | 0.069 | Analgesic, opioid | |||
| 0.027 | 0.022 | 0.027 | Liver X receptor beta antagonist | |||
| 0.019 | 0.014 | 0.019 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.051 | 0.047 | 0.051 | DNA helicase inhibitor | |||
| 0.02 | 0.016 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.019 | 0.015 | 0.019 | Retinoic acid alpha receptor antagonist | |||
| 0.024 | 0.02 | 0.024 | Prostaglandin EP4 antagonist | |||
| 0.036 | 0.033 | 0.036 | 5 Hydroxytryptamine 2B agonist | |||
| 0.042 | 0.038 | 0.042 | Carbonic anhydrase VII inhibitor | |||
| 0.052 | 0.049 | 0.052 | Immunoglobulin Fc receptor antagonist | |||
| 0.075 | 0.072 | 0.075 | NMDA receptor antagonist | |||
| 0.014 | 0.011 | 0.014 | Calcium-sensing receptor antagonist | |||
| 0.014 | 0.012 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.029 | 0.026 | 0.029 | Cholesterol ester transfer protein antagonist | |||
| 0.021 | 0.019 | 0.021 | Retinoic acid gamma receptor agonist | |||
| 0.036 | 0.034 | 0.036 | Membrane dipeptidase inhibitor | |||
| 0.017 | 0.016 | 0.017 | Estrogen-related receptor gamma agonist | |||
| 0.013 | 0.011 | 0.013 | DNA polymerase III polC-type inhibitor | |||
| 0.112 | 0.11 | 0.112 | Cytidine deaminase inhibitor | |||
| 0.052 | 0.051 | 0.052 | Botulinum neurotoxin type A inhibitor | |||
| 0.026 | 0.025 | 0.026 | Estrogen-related receptor gamma antagonist | |||
| 0.022 | 0.021 | 0.022 | Prostaglandin H2 antagonist | |||
| 0.01 | 0.009 | 0.01 | Imidazoline I2 receptor antagonist | |||
| 0.019 | 0.024 | 0.025 | Dopamine D1 agonist | 0.025 0.013 CID_154699648 | CID_154699648 | |
| 0.036 | 0.041 | 0.038 | Guanylate cyclase inhibitor | 0.038 0.037 CID_154699648 | CID_154699648 | |
| 0.079 | 0.086 | 0.135 | Uric acid excretion stimulant | 0.135 0.029 CID_154699648 | CID_154699648 | |
| 0.013 | 0.024 | 0.018 | Telomerase stimulant | 0.018 0.011 CID_154699648 | CID_154699648 | |
| 0.038 | 0.054 | 0.085 | Aldose reductase inhibitor | 0.085 0.022 CID_154699648 | CID_154699648 | |
| 0.124 | 0.139 | 0.219 | Interleukin 6 antagonist | 0.219 0.031 CID_154699648 | CID_154699648 | |
| 0.05 | 0.069 | 0.078 | Nitric oxide donor | 0.078 0.024 CID_154699648 | CID_154699648 | |
| 0.016 | 0.04 | 0.065 | Protein 30S ribosomal subunit inhibitor | 0.065 0.005 CID_154699648 | CID_154699648 | |
| 0.04 | 0.069 | 0.073 | Alpha-mannosidase inhibitor | 0.073 0.015 CID_154699648 | CID_154699648 | |
| 0.03 | 0.066 | 0.069 | Mannosidase inhibitor | 0.069 0.012 CID_154699648 | CID_154699648 | |
| 0.031 | 0.071 | 0.052 | Carbonic anhydrase XIV inhibitor | 0.052 0.03 CID_154699648 | CID_154699648 | |
| 0.015 | 0.055 | 0.046 | Arginase inhibitor | 0.046 0.017 CID_154699648 | CID_154699648 | |
| 0.13 | 0.17 | 0.339 | Platelet antagonist | 0.339 0.041 CID_154699648 | CID_154699648 | |
| 0.18 | 0.227 | 0.412 | Interleukin 2 agonist | 0.412 0.024 CID_154699648 | CID_154699648 | |
| 0.029 | 0.083 | 0.05 | Microtubule stabilization | 0.05 0.028 CID_154699648 | CID_154699648 | |
| 0.095 | 0.153 | 0.168 | DNA repair enzyme inhibitor | 0.168 0.019 CID_154699648 | CID_154699648 | |
| 0.027 | 0.088 | 0.059 | Neuraminidase (Influenza A) inhibitor | 0.059 0.013 CID_154699648 | CID_154699648 | |
| 0.016 | 0.078 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.016 CID_154699648 | CID_154699648 | |
| 0.002 | 0.074 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 CID_154699648 | CID_154699648 | |
| 0.041 | 0.115 | 0.066 | Adenine nucleotide translocase inhibitor | 0.066 0.019 CID_154699648 | CID_154699648 | |
| 0.024 | 0.112 | 0.11 | Protein 50S ribosomal subunit inhibitor | 0.11 0.011 CID_154699648 | CID_154699648 | |
| 0.147 | 0.24 | 0.483 | Immunomodulator | 0.483 0.026 CID_154699648 | CID_154699648 | |
| 0.04 | 0.161 | 0.064 | Lipocortins synthesis agonist | 0.064 0.029 CID_154699648 | CID_154699648 | |
| 0.056 | 0.199 | 0.108 | Multidrug resistance-associated protein 1 inhibitor | 0.108 0.065 CID_154699648 | CID_154699648 | |
| 0.019 | 0.163 | 0.076 | Antibiotic Aminoglycoside-like | 0.076 0.005 CID_154699648 | CID_154699648 | |
| 0.044 | 0.204 | 0.135 | Cell adhesion molecule inhibitor | 0.135 0.019 CID_154699648 | CID_154699648 | |
| 0.044 | 0.209 | 0.077 | Falcipain 2 inhibitor | 0.077 0.074 CID_154699648 | CID_154699648 | |
| 0.045 | 0.213 | 0.079 | Falcipain inhibitor | 0.079 0.075 CID_154699648 | CID_154699648 | |
| 0.1 | 0.283 | 0.144 | CC chemokine 6 receptor antagonist | 0.144 0.032 CID_154699648 | CID_154699648 | |
| 0.037 | 0.235 | 0.122 | DNA intercalator | 0.122 0.057 CID_154699648 | CID_154699648 | |
| 0.054 | 0.27 | 0.103 | Interleukin 12 antagonist | 0.103 0.05 CID_154699648 | CID_154699648 | |
| 0.028 | 0.251 | 0.082 | Histone deacetylase stimulant | 0.082 0.042 CID_154699648 | CID_154699648 | |
| 0.028 | 0.251 | 0.082 | Histone deacetylase SIRT1 stimulant | 0.082 0.042 CID_154699648 | CID_154699648 | |
| 0.024 | 0.487 | 0.204 | Anticoagulant | 0.204 0.051 CID_154699648 | CID_154699648 | |
| 0.016 | 0.491 | 0.079 | Factor IXa inhibitor | 0.079 0.016 CID_154699648 | CID_154699648 | |
| 0.01 | 0.605 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 CID_154699648 | CID_154699648 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |